Caribou Biosciences, Inc. (CRBU) Tops Q2 EPS by 7c

Caribou Biosciences, Inc. (NASDAQ: CRBU) reported Q2 EPS of ($0.24), $0.07 better than the analyst estimate of ($0.31).

For earnings history and earnings-related data on Caribou Biosciences, Inc. (CRBU) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Metalla Royalty & Streaming Ltd. (MTA) Reports In-Line Q2 EPS
• KULR Technology Group (KULR) Misses Q2 EPS by 39c